While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

CNBC’s Angelica Peebles sits down with Lilly’s Head of Oncology, Jake Van Naarden, to discuss what’s next in Lilly’s oncology ...

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...

As consumers taking medications like Ozempic cut back on eating out, about 70% are spending more on cooking at home, ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

The drinks contain a mix of protein and vitamins that will help GLP-1 users reduce weight in a healthy manner.